Amanda Hamilton recently had her article "What Can the FTC Do about Orphan Drug Prices?" published in the Antitrust Health Care Chronicle for August 2017. Her article analyzes what the FTC looks for when investigating orphan pharmaceutical price claims.
Read the article here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.